USD 1.0
(1.18%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.54 Million USD | -85.98% |
2022 | 18.14 Million USD | 36.91% |
2021 | 13.25 Million USD | 2176.8% |
2020 | 582 Thousand USD | -95.85% |
2019 | 14.02 Million USD | 51.26% |
2018 | 9.27 Million USD | 54.78% |
2017 | 5.99 Million USD | 46.93% |
2016 | 4.07 Million USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | -100.0% |
2011 | 276.25 Thousand USD | -74.36% |
2010 | 1.07 Million USD | 0.0% |
2009 | - USD | -100.0% |
2008 | 50 Thousand USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 10 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 1.92 Million USD | -24.16% |
2024 Q2 | 13.67 Million USD | 608.98% |
2023 FY | 2.54 Million USD | -85.98% |
2023 Q4 | 2.54 Million USD | -85.12% |
2023 Q3 | 17.09 Million USD | -5.04% |
2023 Q2 | 17.99 Million USD | -0.4% |
2023 Q1 | 18.07 Million USD | -0.39% |
2022 Q4 | 18.14 Million USD | 39.45% |
2022 Q1 | 13.17 Million USD | -0.59% |
2022 FY | 18.14 Million USD | 36.91% |
2022 Q2 | 13.09 Million USD | -0.61% |
2022 Q3 | 13 Million USD | -0.63% |
2021 Q1 | 461.06 Thousand USD | -20.73% |
2021 FY | 13.25 Million USD | 2176.8% |
2021 Q2 | 13.01 Million USD | 2722.17% |
2021 Q3 | 13.38 Million USD | 2.87% |
2021 Q4 | 13.25 Million USD | -1.01% |
2020 Q3 | 6.69 Million USD | -27.83% |
2020 FY | 582 Thousand USD | -95.85% |
2020 Q1 | 11.44 Million USD | -18.39% |
2020 Q2 | 9.27 Million USD | -19.01% |
2020 Q4 | 581.63 Thousand USD | -91.31% |
2019 Q4 | 14.02 Million USD | 10.93% |
2019 Q3 | 12.64 Million USD | 26.19% |
2019 Q2 | 10.02 Million USD | 8.12% |
2019 Q1 | 9.26 Million USD | -0.07% |
2019 FY | 14.02 Million USD | 51.26% |
2018 Q1 | 9.86 Million USD | 64.71% |
2018 Q3 | 9.91 Million USD | 0.24% |
2018 Q4 | 9.27 Million USD | -6.48% |
2018 FY | 9.27 Million USD | 54.78% |
2018 Q2 | 9.89 Million USD | 0.24% |
2017 Q4 | 5.99 Million USD | -13.98% |
2017 Q2 | 7.94 Million USD | 115.96% |
2017 FY | 5.99 Million USD | 46.93% |
2017 Q1 | 3.67 Million USD | -9.84% |
2017 Q3 | 6.96 Million USD | -12.27% |
2016 Q4 | 4.07 Million USD | -8.96% |
2016 FY | 4.07 Million USD | 0.0% |
2016 Q3 | 4.47 Million USD | -8.22% |
2016 Q2 | 4.88 Million USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 FY | - USD | -100.0% |
2012 Q1 | - USD | -100.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 Q4 | 276.25 Thousand USD | 22.88% |
2011 Q1 | 493.84 Thousand USD | -54.16% |
2011 Q2 | 526.55 Thousand USD | 6.62% |
2011 Q3 | 224.81 Thousand USD | -57.3% |
2011 FY | 276.25 Thousand USD | -74.36% |
2010 Q3 | - USD | 0.0% |
2010 FY | 1.07 Million USD | 0.0% |
2010 Q4 | 1.07 Million USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | -100.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q1 | - USD | -100.0% |
2008 Q1 | 100 Thousand USD | 0.0% |
2008 Q4 | 50 Thousand USD | 0.0% |
2008 Q3 | 50 Thousand USD | 0.0% |
2008 Q2 | 50 Thousand USD | -50.0% |
2008 FY | 50 Thousand USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | -100.0% |
2006 FY | - USD | -100.0% |
2006 Q1 | 10 Thousand USD | 0.0% |
2005 Q4 | 10 Thousand USD | 0.0% |
2005 Q3 | 10 Thousand USD | 0.0% |
2005 Q1 | 10 Thousand USD | 0.0% |
2005 FY | 10 Thousand USD | 0.0% |
2005 Q2 | 10 Thousand USD | 0.0% |
2004 Q4 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 36.1 Million USD | 92.956% |
BrainsWay Ltd. | 239 Thousand USD | -963.957% |
Cerus Corporation | 59.79 Million USD | 95.747% |
Envoy Medical, Inc. | 404 Thousand USD | -529.42% |
electroCore, Inc. | 537 Thousand USD | -373.53% |
Helius Medical Technologies, Inc. | 12 Thousand USD | -21090.475% |
IceCure Medical Ltd | 376 Thousand USD | -576.292% |
Inogen, Inc. | 18.27 Million USD | 86.082% |
OrthoPediatrics Corp. | 13.45 Million USD | 81.107% |
Lucid Diagnostics Inc. | 199 Thousand USD | -1177.818% |
Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -599.117% |
MaxCyte, Inc. | 17.96 Million USD | 85.849% |
NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -4499.626% |
Nexalin Technology, Inc. | - USD | -Infinity% |
Orthofix Medical Inc. | 93.1 Million USD | 97.269% |
PAVmed Inc | 2.96 Million USD | 14.093% |
Rapid Micro Biosystems, Inc. | 6.21 Million USD | 59.079% |
RxSight, Inc. | 1.21 Million USD | -109.98% |
Sight Sciences, Inc. | 31.7 Million USD | 91.98% |
SI-BONE, Inc. | 36.06 Million USD | 92.949% |
TELA Bio, Inc. | 40.51 Million USD | 93.724% |
Treace Medical Concepts, Inc. | 53 Million USD | 95.203% |
Vivos Therapeutics, Inc. | 1.52 Million USD | -67.183% |
Acutus Medical, Inc. | 32.65 Million USD | 92.213% |
Talis Biomedical Corporation | 16.78 Million USD | 84.851% |
Spectral AI, Inc. | - USD | -Infinity% |
Nano-X Imaging Ltd. | 4.04 Million USD | 37.136% |
CVRx, Inc. | 30.38 Million USD | 91.63% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
PetVivo Holdings, Inc. | 1.01 Million USD | -150.052% |
Bioventus Inc. | 366.99 Million USD | 99.307% |
Venus Concept Inc. | 70.79 Million USD | 96.408% |
TriSalus Life Sciences, Inc. | 1.24 Million USD | -104.41% |
LivaNova PLC | 568.54 Million USD | 99.553% |
908 Devices Inc. | 3.92 Million USD | 35.28% |
Alphatec Holdings, Inc. | 511.03 Million USD | 99.502% |
Nemaura Medical Inc. | 3.08 Million USD | 17.644% |
NeuroPace, Inc. | 56.95 Million USD | 95.535% |
LENSAR, Inc. | 1.75 Million USD | -45.306% |
Apyx Medical Corporation | 33.18 Million USD | 92.337% |
Cutera, Inc. | 418.69 Million USD | 99.393% |
STRATA Skin Sciences, Inc. | 15.04 Million USD | 83.097% |
BioSig Technologies, Inc. | 103 Thousand USD | -2368.793% |
Anika Therapeutics, Inc. | 26.9 Million USD | 90.548% |
ClearPoint Neuro, Inc. | 9.94 Million USD | 74.441% |
Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.829% |
Axonics, Inc. | 25.84 Million USD | 90.159% |
Outset Medical, Inc. | 134.59 Million USD | 98.111% |
IRIDEX Corporation | 1.75 Million USD | -45.223% |
PROCEPT BioRobotics Corporation | 51.33 Million USD | 95.047% |
IRadimed Corporation | 1.61 Million USD | -57.445% |
Tivic Health Systems, Inc. | 176 Thousand USD | -1344.805% |
INVO Bioscience, Inc. | 6.77 Million USD | 62.473% |
Telesis Bio, Inc. | 5.26 Million USD | 51.739% |
Viemed Healthcare, Inc. | 5.97 Million USD | 57.415% |
Varex Imaging Corporation | 464.2 Million USD | 99.452% |
Quipt Home Medical Corp. | 60.82 Million USD | 95.819% |
Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -332.459% |
Pulmonx Corporation | 35.08 Million USD | 92.753% |
Dynatronics Corporation | 3.25 Million USD | 21.962% |
Modular Medical, Inc. | 817 Thousand USD | -211.243% |
ReShape Lifesciences Inc. | 151 Thousand USD | -1584.011% |
Semler Scientific, Inc. | 70 Thousand USD | -3532.653% |
InMode Ltd. | 6.61 Million USD | 61.548% |
Bruker Corporation | 1.14 Billion USD | 99.778% |
DexCom, Inc. | 2.57 Billion USD | 99.901% |
Align Technology, Inc. | 96.96 Million USD | 97.378% |
Viveve Medical, Inc. | 5.12 Million USD | 50.374% |
ZimVie Inc. | 508.79 Million USD | 99.5% |
Movano Inc. | 15.00 USD | -16952280.0% |
Cytek Biosciences, Inc. | 18.12 Million USD | 85.97% |
Nexalin Technology, Inc. | - USD | -Infinity% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.362% |
Profound Medical Corp. | 4.97 Million USD | 48.881% |
Insulet Corporation | 1.36 Billion USD | 99.814% |
enVVeno Medical Corporation | 1.06 Million USD | -138.99% |
Surmodics, Inc. | 29.4 Million USD | 91.352% |
iCAD, Inc. | 273 Thousand USD | -831.449% |
Nuwellis, Inc. | 221 Thousand USD | -1050.614% |
Biotricity, Inc. | 10.85 Million USD | 76.576% |
iRhythm Technologies, Inc. | 34.95 Million USD | 92.724% |
Aethlon Medical, Inc. | 649.75 Thousand USD | -291.359% |
InspireMD, Inc. | 1.03 Million USD | -144.977% |
PAVmed Inc. | 2.96 Million USD | 14.093% |
BIOLASE, Inc. | 13.98 Million USD | 81.817% |
Beyond Air, Inc. | 14.72 Million USD | 82.726% |
FONAR Corporation | 37.92 Million USD | 93.296% |
AxoGen, Inc. | 46.6 Million USD | 94.544% |
Vivani Medical, Inc. | 19.31 Million USD | 86.833% |
Tactile Systems Technology, Inc. | 44.61 Million USD | 94.3% |
Inari Medical, Inc. | 30.35 Million USD | 91.623% |
UFP Technologies, Inc. | 28 Million USD | 90.918% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 434.04 Thousand USD | -485.851% |
Tenon Medical, Inc. | 428 Thousand USD | -494.125% |
Autonomix Medical, Inc. Common Stock | 1 Million USD | -153.778% |
Co-Diagnostics, Inc. | 2.15 Million USD | -18.153% |
AdaptHealth Corp. | 2.09 Billion USD | 99.879% |
Sintx Technologies, Inc. | 3.68 Million USD | 31.032% |
NanoVibronix, Inc. | - USD | -Infinity% |
Quanterix Corporation | 37.22 Million USD | 93.169% |
Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -332.459% |
Sensus Healthcare, Inc. | 596 Thousand USD | -326.654% |
Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.715% |
TransMedics Group, Inc. | 506.2 Million USD | 99.498% |
ReWalk Robotics Ltd. | 607 Thousand USD | -318.922% |
NeuroMetrix, Inc. | 92.48 Thousand USD | -2649.48% |
Hyperfine, Inc. | 64 Thousand USD | -3873.214% |
Establishment Labs Holdings Inc. | 188.73 Million USD | 98.653% |
Biomerica, Inc. | 459 Thousand USD | -453.999% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | -465.729% |
Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -1238.437% |
Silk Road Medical, Inc | 75.62 Million USD | 96.638% |